Press
News & Press
KdT and its founders in the press: frontier science becoming industry.
CoverageDate
- Can AI Reinvent How America Makes Medicine?8/27/26
- Is China Going to Control Your Medicine?8/11/26
- Oracle Health Extends AI into the Operating Room in Collaboration with Theator6/24/26
- Exthymic Receives ARPA-H SCOPE Award of Up to $25M6/18/26
- Rejuvenate Bio Announces $6M Financing and R&D Collaboration with Merck Animal Health6/8/26
- He Managed Finances on Tesla’s Model 3. Now He Wants to Break China’s Grip on Chip-Making Materials5/8/26
- Roche to Acquire PathAI in Deal Potentially Worth More Than $1B5/7/26
- Motif Neurotech Receives FDA IDE Authorization to Begin First Therapeutic BCI Trial4/27/26
- Cirsium Biosciences Opens AAV Gene Therapy Manufacturing Facility4/17/26
- Abridge Partners with NEJM and JAMA to Integrate Peer-Reviewed Evidence4/15/26
- Astellas Exercises Dyno Therapeutics Capsid License for Skeletal Muscle-Targeted Gene Delivery4/8/26
- Zag Bio: Rewiring the Thymus for Antigen-Specific Tolerance4/1/26
- Nosis Bio Expands Johnson & Johnson Collaboration into Neurology3/24/26
- PathAI Receives FDA Breakthrough Device Designation for PathAssist Derm3/3/26
- Labcorp Expands PathAI Pact to Roll Out Digital Pathology Platform in the U.S.2/25/26
- Sensei Acquires Faeth Therapeutics and Announces $200M Private Placement2/18/26
- SURGE Therapeutics Completes Phase 1 Dosing of Intraoperative Immunotherapy2/12/26
- Biotech Needs Its Own David Sacks1/7/26
- Leucid Bio and Syenex Announce Strategic Collaboration for In Vivo CAR-T Cell Engineering12/15/25
- PathAI’s AIM-MASH Becomes First AI-Powered Tool Qualified for MASH Clinical Trials12/9/25
- March Biosciences Presents Interim Phase 2 Data for MB-10512/8/25
- STRM.BIO Awarded ARPA-H Contract for In Vivo Cell Engineering and Gene Therapy12/3/25
- Terray Therapeutics Achieves AI-Enabled Drug Discovery Milestone with Bristol Myers Squibb12/3/25
- Episode 114: How AI, Supply Chains, and Smart Strategy Are Redefining Biotech Investment and Venture Capital11/26/25
- March Biosciences Receives FDA RMAT Designation for MB-10511/11/25
- Zag Bio Launches with $80M Financing10/28/25
- Checkerspot and Huvepharma Partner to Commercialize Human Milk Fat Analog10/7/25
- Remedy Robotics Reports Fully Remote Diagnostic Cerebral Angiograms10/6/25
- Debut Raises $20M to Accelerate AI Ingredient Discovery8/26/25
- PathAI Receives FDA Clearance for AISight Dx Platform6/30/25
- Abridge Raises $300M Series E6/24/25
- Azitra Reports Early Phase 1b Safety Data in Netherton Syndrome6/17/25
- PHNX Materials Raises $2.5M Seed Round Co-Led by KdT Ventures4/21/25
- Integrated DNA Technologies and Elegen Partner on Long DNA Synthesis3/31/25
- Character Biosciences Raises $93M Series B3/25/25
- lululemon and ZymoChem Announce Multi-Year Partnership on Bio-Based Nylon3/19/25
- Montara Therapeutics Closes $20M Seed Expansion3/13/25
- Nosis Bio and Daiichi Sankyo Collaborate on Cell-Targeted RNA Medicines3/11/25
- STAT Highlights the Next Generation of Biotech Venture Capital Firms2/27/25
- Reverb Therapeutics Raises $12M Seed Round2/19/25
- Abridge Raises $250M Series D2/17/25
- LLNL and Canaery Develop Neural Interface Technology for Scent Detection2/13/25
- Onc.AI Receives FDA Breakthrough Device Designation for Serial CT Response Score2/6/25
- Roche Exercises Option for Dyno’s Next-Generation AAV Vector1/13/25
- Character Biosciences and Bausch + Lomb Announce Precision Ophthalmology Collaboration1/10/25
- Vividion Therapeutics Acquires Tavros Therapeutics1/8/25
- KdT Ventures Nabs Over $100 Million for Early-Stage Investments12/19/24
- NGM Bio and KdT Ventures Enter into Worldwide License Agreement for NGM31312/19/24
- ZymoChem Closes $21M Series A Round Led by Breakout Ventures1/16/24
- Terray Therapeutics Announces Multi-Target Collaboration with Bristol Myers Squibb12/14/23
- Terray Therapeutics Announces Investment from NVIDIA for Generative AI Design11/9/23
- ZymoChem Awarded $4 Million to Manufacture Bio-Based Polymers11/8/23
- Bayer-partnered Azitra hopes to apply $7.5M IPO proceeds to near-clinical dermatology pipeline6/22/23
- Months after adding $60M to coffers, AI startup Terray nabs discovery pact with Google's Calico10/12/22
- 'Pluck those diamonds': Bayer's Vividion eyes up to nine oncology targets from Duke spinout10/12/22
- Ginkgo Bioworks acquires circular RNA biotech Circularis10/6/22